Ribosomal proteins as novel players in tumorigenesis

Cancer and Metastasis Reviews

Volumn 33, Issue 1, 2014, Pages 115-141

  De Las Heras Rubio, A ^a   Perucho, L ^a   Paciucci, R ^a   Vilardell, J ^b   Lleonart, M E ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Cancer; Oncogenes; Ribosomal proteins (RPs); Ribosome biogenesis; Tumor suppressor genes

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; RAF PROTEIN; RAS PROTEIN; RETINOBLASTOMA PROTEIN; RIBOSOME PROTEIN; TUMOR SUPPRESSOR PROTEIN;

BIOGENESIS; CANCER GROWTH; CARCINOGENESIS; DEREGULATION; GENE MUTATION; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; TUMOR SUPPRESSOR GENE; BIOLOGICAL MODEL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASMS; PATHOLOGY; SIGNAL TRANSDUCTION;

CARCINOGENESIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, GENETIC; NEOPLASM METASTASIS; NEOPLASMS; RIBOSOMAL PROTEINS; RIBOSOMES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84899930708     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-013-9460-6     Document Type: Review

References (237)

1. Sollner-Webb, B., & Mougey, E. B. (1991). News from the nucleolus: rRNA gene expression. Trends in Biochemical Sciences, 16(2), 58-62.
2. Uechi, T., Tanaka, T., & Kenmochi, N. (2001). A complete map of the human ribosomal protein genes: assignment of 80 genes to the cytogenetic map and implications for human disorders. Genomics, 72(3), 223-230.
3. Fatica, A., & Tollervey, D. (2002). Making ribosomes. Current Opinion in Cell Biology, 14(3), 313-318.
4. Bortoluzzi, S., d'Alessi, F., Romualdi, C., & Danieli, G. A. (2001). Differential expression of genes coding for ribosomal proteins in different human tissues. Bioinformatics, 17(12), 1152-1157.
5. Ishii, K., Washio, T., Uechi, T., Yoshihama, M., Kenmochi, N., & Tomita, M. (2006). Characteristics and clustering of human ribosomal protein genes. BMC Genomics, 737.
6. Shen, D. W., Liang, X. J., Suzuki, T., & Gottesman, M. M. (2006). Identification by functional cloning from a retroviral cDNA library of cDNAs for ribosomal protein L36 and the 10-kDa heat shock protein that confer cisplatin resistance. Molecular Pharmacology, 69(4), 1383-1388.
7. Du, J., Shi, Y., Pan, Y., Jin, X., Liu, C., Liu, N., et al. (2005). Regulation of multidrug resistance by ribosomal protein l6 in gastric cancer cells. Cancer Biology and Therapy, 4(2), 242-247.
8. Kim, J., Chubatsu, L. S., Admon, A., Stahl, J., Fellous, R., & Linn, S. (1995). Implication of mammalian ribosomal protein S3 in the processing of DNA damage. Journal of Biological Chemistry, 270(23), 13620-13629.
9. Fisher, E. M., Beer-Romero, P., Brown, L. G., Ridley, A., McNeil, J. A., Lawrence, J. B., et al. (1990). Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for turner syndrome. Cell, 63(6), 1205-1218.
10. Poddar, D., Basu, A., Baldwin, W. M., 3rd, Kondratov, R. V., Barik, S., & Mazumder, B. (2013). An extraribosomal function of ribosomal protein L13a in macrophages resolves inflammation. Journal of Immunology, 190(7), 3600-3612.
11. Derenzini, M., Trere, D., Pession, A., Govoni, M., Sirri, V., & Chieco, P. (2000). Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. Journal of Pathology, 191(2), 181-186.
12. Pomeroy, S. L., Tamayo, P., Gaasenbeek, M., Sturla, L. M., Angelo, M., McLaughlin, M. E., et al. (2002). Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature, 415(6870), 436-442.
13. Zhang, L., Zhou, W., Velculescu, V. E., Kern, S. E., Hruban, R. H., Hamilton, S. R., et al. (1997). Gene expression profiles in normal and cancer cells. Science, 276(5316), 1268-1272.
14. Bee, A., Ke, Y., Forootan, S., Lin, K., Beesley, C., Forrest, S. E., et al. (2006). Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clinical Cancer Research, 12(7 Pt 1), 2061-2065.
15. Huang, X. P., Zhao, C. X., Li, Q. J., Cai, Y., Liu, F. X., Hu, H., et al. (2006). Alteration of RPL14 in squamous cell carcinomas and preneoplastic lesions of the esophagus. Gene, 366(1), 161-168.
16. Clemens, M. J. (2004). Targets and mechanisms for the regulation of translation in malignant transformation. Oncogene, 23(18), 3180-3188.
17. Pestov, D. G., Strezoska, Z., & Lau, L. F. (2001). Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Molecular and Cellular Biology, 21(13), 4246-4255.
18. Boon, K., Caron, H. N., van Asperen, R., Valentijn, L., Hermus, M. C., van Sluis, P., et al. (2001). N-myc enhances the expression of a large set of genes functioning in ribosome biogenesis and protein synthesis. Embo J, 20(6), 1383-1393.
19. Williams, G. T., & Farzaneh, F. (2013). Are snoRNAs and snoRNA host genes new players in cancer? Nature Reviews Cancer, 12(2), 84-88.
20. Dragon, F., Gallagher, J. E., Compagnone-Post, P. A., Mitchell, B. M., Porwancher, K. A., Wehner, K. A., et al. (2002). A large nucleolar U3 ribonucleoprotein required for 18S ribosomal RNA biogenesis. Nature, 417(6892), 967-970.
21. Su, H., Xu, T., Ganapathy, S., Shadfan, M., Long, M., Huang, T. H., et al. (2013). Elevated snoRNA biogenesis is essential in breast cancer. Oncogene. doi: 10.1038/onc.2013.89.
22. Laferte, A., Favry, E., Sentenac, A., Riva, M., Carles, C., & Chedin, S. (2006). The transcriptional activity of RNA polymerase I is a key determinant for the level of all ribosome components. Genes and Development, 20(15), 2030-2040.
23. Derenzini, M., Trere, D., Pession, A., Montanaro, L., Sirri, V., & Ochs, R. L. (1998). Nucleolar function and size in cancer cells. American Journal of Pathology, 152(5), 1291-1297.
24. Yuan, X., Zhao, J., Zentgraf, H., Hoffmann-Rohrer, U., & Grummt, I. (2002). Multiple interactions between RNA polymerase I, TIF-IA and TAF(I) subunits regulate preinitiation complex assembly at the ribosomal gene promoter. EMBO Reports, 3(11), 1082-1087.
25. Zhao, J., Yuan, X., Frodin, M., & Grummt, I. (2003). ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Molecular Cell, 11(2), 405-413.
26. Montanaro, L., Mazzini, G., Barbieri, S., Vici, M., Nardi-Pantoli, A., Govoni, M., et al. (2007). Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein- and p53-deficient and proficient human osteosarcoma cell lines. Cell Proliferation, 40(4), 532-549.
27. Drygin, D., Lin, A., Bliesath, J., Ho, C. B., O'Brien, S. E., Proffitt, C., et al. (2011). Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth. Cancer Research, 71(4), 1418-1430.
28. Strezoska, Z., Pestov, D. G., & Lau, L. F. (2000). Bop1 is a mouse WD40 repeat nucleolar protein involved in 28S and 5. 8S RRNA processing and 60S ribosome biogenesis. Molecular and Cellular Biology, 20(15), 5516-5528.
29. Jouffe, C., Cretenet, G., Symul, L., Martin, E., Atger, F., Naef, F., et al. (2013). The circadian clock coordinates ribosome biogenesis. PLoS Biology, 11(1), e1001455.
30. De Benedetti, A., & Rhoads, R. E. (1990). Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proceedings of the National Academy of Sciences of the United States of America, 87(21), 8212-8216.
31. Koromilas, A. E., Lazaris-Karatzas, A., & Sonenberg, N. (1992). MRNAs containing extensive secondary structure in their 5′ non-coding region translate efficiently in cells overexpressing initiation factor eIF-4E. EMBO Journal, 11(11), 4153-4158.
32. Svitkin, Y. V., Herdy, B., Costa-Mattioli, M., Gingras, A. C., Raught, B., & Sonenberg, N. (2005). Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Molecular and Cellular Biology, 25(23), 10556-10565.
33. Sonenberg, N., & Hinnebusch, A. G. (2009). Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell, 136(4), 731-745.
34. Jopling, C. L., Spriggs, K. A., Mitchell, S. A., Stoneley, M., & Willis, A. E. (2004). L-Myc protein synthesis is initiated by internal ribosome entry. RNA, 10(2), 287-298.
35. Yang, D. Q., Halaby, M. J., & Zhang, Y. (2006). The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage. Oncogene, 25(33), 4613-4619.
36. Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., et al. (2011). Initial genome sequencing and analysis of multiple myeloma. Nature, 471(7339), 467-472.
37. Scheid, M. P., & Woodgett, J. R. (2003). Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Letters, 546(1), 108-112.
38. Dubrovska, A., Kim, S., Salamone, R. J., Walker, J. R., Maira, S. M., Garcia-Echeverria, C., et al. (2009). The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations. Proceedings of the National Academy of Sciences of the United States of America, 106(1), 268-273.
39. James, M. J., & Zomerdijk, J. C. (2004). Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. Journal of Biological Chemistry, 279(10), 8911-8918.
40. Zhu, J., Blenis, J., & Yuan, J. (2008). Activation of PI3K/Akt and MAPK pathways regulates Myc-mediated transcription by phosphorylating and promoting the degradation of Mad1. Proceedings of the National Academy of Sciences of the United States of America, 105(18), 6584-6589.
41. Vivanco, I., & Sawyers, C. L. (2002). The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nature Reviews Cancer, 2(7), 489-501.
42. Yin, Y., & Shen, W. H. (2008). PTEN: a new guardian of the genome. Oncogene, 27(41), 5443-5453.
43. Zhang, C., Comai, L., & Johnson, D. L. (2005). PTEN represses RNA polymerase I transcription by disrupting the SL1 complex. Molecular and Cellular Biology, 25(16), 6899-6911.
44. Toschi, A., Lee, E., Xu, L., Garcia, A., Gadir, N., & Foster, D. A. (2009). Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin. Molecular and Cellular Biology, 29(6), 1411-1420.
45. Hannan, K. M., Brandenburger, Y., Jenkins, A., Sharkey, K., Cavanaugh, A., Rothblum, L., et al. (2003). MTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF. Molecular and Cellular Biology, 23(23), 8862-8877.
46. Mayer, C., & Grummt, I. (2006). Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene, 25(48), 6384-6391.
47. Innes, F., Ramsbottom, B., & White, R. J. (2006). A test of the model that RNA polymerase III transcription is regulated by selective induction of the 110 kDa subunit of TFIIIC. Nucleic Acids Research, 34(11), 3399-3407.
48. Shor, B., Wu, J., Shakey, Q., Toral-Barza, L., Shi, C., Follettie, M., et al. (2010). Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. Journal of Biological Chemistry, 285(20), 15380-15392.
49. Honma, Y., Kitamura, A., Shioda, R., Maruyama, H., Ozaki, K., Oda, Y., et al. (2006). TOR regulates late steps of ribosome maturation in the nucleoplasm via Nog1 in response to nutrients. Embo J, 25(16), 3832-3842.
50. Castellvi, J., Garcia, A., Rojo, F., Ruiz-Marcellan, C., Gil, A., Baselga, J., et al. (2006). Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer. Cancer, 107(8), 1801-1811.
51. Raught, B., Peiretti, F., Gingras, A. C., Livingstone, M., Shahbazian, D., Mayeur, G. L., et al. (2004). Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO Journal, 23(8), 1761-1769.
52. Magnuson, B., Ekim, B., & Fingar, D. C. (2012). Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochemical Journal, 441(1), 1-21.
53. Bjornsti, M. A., & Houghton, P. J. (2004). The TOR pathway: a target for cancer therapy. Nature Reviews Cancer, 4(5), 335-348.
54. Wang, H. D., Trivedi, A., & Johnson, D. L. (1998). Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Molecular and Cellular Biology, 18(12), 7086-7094.
55. Felton-Edkins, Z. A., Fairley, J. A., Graham, E. L., Johnston, I. M., White, R. J., & Scott, P. H. (2003). The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB. EMBO Journal, 22(10), 2422-2432.
56. Miluzio, A., Beugnet, A., Grosso, S., Brina, D., Mancino, M., Campaner, S., et al. (2011). Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth. Cancer Cell, 19(6), 765-775.
57. Lee, T., Yao, G., Nevins, J., & You, L. (2008). Sensing and integration of Erk and PI3K signals by Myc. PLoS Computational Biology, 4(2), e1000013.
58. Rajasekhar, V. K., Viale, A., Socci, N. D., Wiedmann, M., Hu, X., & Holland, E. C. (2003). Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Molecular Cell, 12(4), 889-901.
59. Bos, J. L. (1989). RAS oncogenes in human cancer: a review. Cancer Research, 49(17), 4682-4689.
60. Di Nicolantonio, F., Arena, S., Tabernero, J., Grosso, S., Molinari, F., Macarulla, T., et al. (2010). Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. Journal of Clinical Investigation, 120(8), 2858-2866.
61. Schmidt, E. V. (2004). The role of c-myc in regulation of translation initiation. Oncogene, 23(18), 3217-3221.
62. Grandori, C., Gomez-Roman, N., Felton-Edkins, Z. A., Ngouenet, C., Galloway, D. A., Eisenman, R. N., et al. (2005). c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I. Nature Cell Biology, 7(3), 311-318.
63. Gomez-Roman, N., Felton-Edkins, Z. A., Kenneth, N. S., Goodfellow, S. J., Athineos, D., Zhang, J., et al. (2006). Activation by c-Myc of transcription by RNA polymerases I, II and III. Biochem Soc Symp (73), 141-154. doi: http://www.ncbi.nlm.nih.gov/pubmed/16626295
64. Kenneth, N. S., Ramsbottom, B. A., Gomez-Roman, N., Marshall, L., Cole, P. A., & White, R. J. (2007). TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription. Proceedings of the National Academy of Sciences of the United States of America, 104(38), 14917-14922.
65. Poortinga, G., Hannan, K. M., Snelling, H., Walkley, C. R., Jenkins, A., Sharkey, K., et al. (2004). MAD1 and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation. EMBO Journal, 23(16), 3325-3335.
66. Schlosser, I., Holzel, M., Murnseer, M., Burtscher, H., Weidle, U. H., & Eick, D. (2003). A role for c-Myc in the regulation of ribosomal RNA processing. Nucleic Acids Research, 31(21), 6148-6156.
67. Holzel, M., Rohrmoser, M., Schlee, M., Grimm, T., Harasim, T., Malamoussi, A., et al. (2005). Mammalian WDR12 is a novel member of the Pes1-Bop1 complex and is required for ribosome biogenesis and cell proliferation. Journal of Cell Biology, 170(3), 367-378.
68. Ruggero, D., Montanaro, L., Ma, L., Xu, W., Londei, P., Cordon-Cardo, C., et al. (2004). The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nature Medicine, 10(5), 484-486.
69. Pourdehnad, M., Truitt, M. L., Siddiqi, I. N., Ducker, G. S., Shokat, K. M., & Ruggero, D. (2013). Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Proceedings of the National Academy of Sciences of the United States of America, 110(29), 11988-11993.
70. Challagundla, K. B., Sun, X. X., Zhang, X., DeVine, T., Zhang, Q., Sears, R. C., et al. (2011). Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Molecular and Cellular Biology, 31(19), 4007-4021.
71. Dai, M., Sun, X., & Lu, H. (2010). Ribosomal protein L11 associates with c-Myc at 5S rRNA and tRNA genes and regulates their expression. Journal of Biological Chemistry, 285.
72. Zhou, X., Hao, Q., Liao, J., Zhang, Q., & Lu, H. (2013). Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene, 32(3), 388-396.
73. Zhou, X., Hao, Q., Liao, J. M., Liao, P., & Lu, H. (2013). Ribosomal protein S14 negatively regulates c-Myc activity. Journal of Biological Chemistry. doi: 10.1074/jbc.M112.445122.
74. Kim, S., Li, Q., Dang, C. V., & Lee, L. A. (2000). Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proceedings of the National Academy of Sciences of the United States of America, 97(21), 11198-11202.
75. Barna, M., Pusic, A., Zollo, O., Costa, M., Kondrashov, N., Rego, E., et al. (2008). Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature, 456(7224), 971-975.
76. Dai, M. S., Arnold, H., Sun, X. X., Sears, R., & Lu, H. (2007). Inhibition of c-Myc activity by ribosomal protein L11. EMBO Journal, 26(14), 3332-3345.
77. Wanzel, M., Russ, A. C., Kleine-Kohlbrecher, D., Colombo, E., Pelicci, P. G., & Eilers, M. (2008). A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nature Cell Biology, 10(9), 1051-1061.
78. Lin, P., & Medeiros, L. J. (2013). The Impact of MYC Rearrangements and "Double Hit" Abnormalities in Diffuse Large B-Cell Lymphoma. Current Hematologic Malignancy Reports. doi: 10.1007/s11899-013-0169-y.
79. Cavanaugh, A. H., Hempel, W. M., Taylor, L. J., Rogalsky, V., Todorov, G., & Rothblum, L. I. (1995). Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature, 374(6518), 177-180.
80. White, R. J., Trouche, D., Martin, K., Jackson, S. P., & Kouzarides, T. (1996). Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature, 382(6586), 88-90.
81. Knudsen, E. S., & Knudsen, K. E. (2008). Tailoring to RB: tumour suppressor status and therapeutic response. Nature Reviews Cancer, 8(9), 714-724.
82. Lane, D. P. (1992). Cancer. p53, guardian of the genome. Nature, 358(6381), 15-16.
83. Holzel, M., Burger, K., Muhl, B., Orban, M., Kellner, M., & Eick, D. (2010). The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword. Oncotarget, 1(1), 43-47.
84. Cairns, C. A., & White, R. J. (1998). p53 is a general repressor of RNA polymerase III transcription. Embo J, 17(11), 3112-3123.
85. Zhai, W., & Comai, L. (2000). Repression of RNA polymerase I transcription by the tumor suppressor p53. Molecular and Cellular Biology, 20(16), 5930-5938.
86. Krastev, D. B., Slabicki, M., Paszkowski-Rogacz, M., Hubner, N. C., Junqueira, M., Shevchenko, A., et al. (2011). A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly. Nature Cell Biology, 13(7), 809-818.
87. Gridasova, A. A., & Henry, R. W. (2005). The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding. Molecular and Cellular Biology, 25(8), 3247-3260.
88. Petroulakis, E., Parsyan, A., Dowling, R. J., LeBacquer, O., Martineau, Y., Bidinosti, M., et al. (2009). p53-dependent translational control of senescence and transformation via 4E-BPs. Cancer Cell, 16(5), 439-446.
89. Loging, W. T., & Reisman, D. (1999). Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. Cancer Epidemiology, Biomarkers and Prevention, 8(11), 1011-1016.
90. Lessard, F., Morin, F., Ivanchuk, S., Langlois, F., Stefanovsky, V., Rutka, J., et al. (2010). The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor TTF-I. Molecular Cell, 38(4), 539-550.
91. Sugimoto, M., Kuo, M. L., Roussel, M. F., & Sherr, C. J. (2003). Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. Molecular Cell, 11(2), 415-424.
92. Kurki, S., Peltonen, K., Latonen, L., Kiviharju, T. M., Ojala, P. M., Meek, D., et al. (2004). Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell, 5(5), 465-475.
93. Itahana, K., Bhat, K. P., Jin, A., Itahana, Y., Hawke, D., Kobayashi, R., et al. (2003). Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation. Molecular Cell, 12(5), 1151-1164.
94. Ayrault, O., Andrique, L., Fauvin, D., Eymin, B., Gazzeri, S., & Seite, P. (2006). Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor phosphorylation. Oncogene, 25(58), 7577-7586.
95. Saporita, A. J., Chang, H. C., Winkeler, C. L., Apicelli, A. J., Kladney, R. D., Wang, J., et al. (2011). RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. Cancer Research, 71(21), 6708-6717.
96. Lowe, S. W., & Sherr, C. J. (2003). Tumor suppression by Ink4a-Arf: progress and puzzles. Current Opinion in Genetics and Development, 13(1), 77-83.
97. Nakao, A., Yoshihama, M., & Kenmochi, N. (2004). RPG: the ribosomal protein gene database. Nucleic Acids Research, 32, D168-D170.
98. Mager, W. H., Planta, R. J., Ballesta, J. G., Lee, J. C., Mizuta, K., Suzuki, K., et al. (1997). A new nomenclature for the cytoplasmic ribosomal proteins of Saccharomyces cerevisiae. Nucleic Acids Research, 25(24), 4872-4875.
99. Warner, J. R., & McIntosh, K. B. (2009). How common are extraribosomal functions of ribosomal proteins? Molecular Cell, 34(1), 3-11.
100. Lam, Y. W., Lamond, A. I., Mann, M., & Andersen, J. S. (2007). Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Current Biology, 17(9), 749-760.
101. Steffen, K. K., MacKay, V. L., Kerr, E. O., Tsuchiya, M., Hu, D., Fox, L. A., et al. (2008). Yeast life span extension by depletion of 60s ribosomal subunits is mediated by Gcn4. Cell, 133(2), 292-302.
102. McIntosh, K. B., & Bonham-Smith, P. C. (2005). The two ribosomal protein L23A genes are differentially transcribed in Arabidopsis thaliana. Genome, 48(3), 443-454.
103. McIntosh, K. B., Bhattacharya, A., Willis, I. M., & Warner, J. R. (2011). Eukaryotic cells producing ribosomes deficient in Rpl1 are hypersensitive to defects in the ubiquitin-proteasome system. PLoS One, 6(8), e23579.
104. Mazumder, B., Sampath, P., Seshadri, V., Maitra, R. K., DiCorleto, P. E., & Fox, P. L. (2003). Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell, 115(2), 187-198.
105. Martinez-Azorin, F., Remacha, M., & Ballesta, J. P. (2008). Functional characterization of ribosomal P1/P2 proteins in human cells. Biochemical Journal, 413(3), 527-534.
106. Kondrashov, N., Pusic, A., Stumpf, C. R., Shimizu, K., Hsieh, A. C., Xue, S., et al. (2011). Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell, 145(3), 383-397.
107. Ron, D., Chen, C. H., Caldwell, J., Jamieson, L., Orr, E., & Mochly-Rosen, D. (1994). Cloning of an intracellular receptor for protein kinase C: a homolog of the beta subunit of G proteins. Proceedings of the National Academy of Sciences of the United States of America, 91(3), 839-843.
108. Dresios, J., Panopoulos, P., & Synetos, D. (2006). Eukaryotic ribosomal proteins lacking a eubacterial counterpart: important players in ribosomal function. Molecular Microbiology, 59(6), 1651-1663.
109. Rabl, J., Leibundgut, M., Ataide, S. F., Haag, A., & Ban, N. (2011). Crystal structure of the eukaryotic 40S ribosomal subunit in complex with initiation factor 1. Science, 331(6018), 730-736.
110. Arimoto, K., Fukuda, H., Imajoh-Ohmi, S., Saito, H., & Takekawa, M. (2008). Formation of stress granules inhibits apoptosis by suppressing stress-responsive MAPK pathways. Nature Cell Biology, 10(11), 1324-1332.
111. Ceci, M., Welshhans, K., Ciotti, M. T., Brandi, R., Parisi, C., Paoletti, F., et al. (2012). RACK1 is a ribosome scaffold protein for beta-actin mRNA/ZBP1 complex. PLoS One, 7(4), e35034.
112. Marques, N., Sese, M., Canovas, V., Valente, F., Bermudo, R., de Torres, I., et al. (2013). Regulation of protein translation and c-Jun expression by prostate tumor overexpressed 1. Oncogene. doi: 10.1038/onc.2013.51.
113. Lopez-Bergami, P., Habelhah, H., Bhoumik, A., Zhang, W., Wang, L. H., & Ronai, Z. (2005). RACK1 mediates activation of JNK by protein kinase C [corrected]. Molecular Cell, 19(3), 309-320.
114. Ruan, Y., Sun, L., Hao, Y., Wang, L., Xu, J., Zhang, W., et al. (2012). Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. Journal of Clinical Investigation, 122(7), 2554-2566.
115. Zhong, X., Li, M., Nie, B., Wu, F., Zhang, L., Wang, E., et al. (2013). Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma. Annals of Surgical Oncology, 20(3), 1044-1052.
116. Wool, I. G. (1996). Extraribosomal functions of ribosomal proteins. Trends in Biochemical Sciences, 21(5), 164-165.
117. Lindstrom, M. S., & Zhang, Y. (2008). Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation. Journal of Biological Chemistry, 283(23), 15568-15576.
118. Ruggero, D., & Pandolfi, P. P. (2003). Does the ribosome translate cancer? Nature Reviews Cancer, 3(3), 179-192.
119. Gil, J., Bernard, D., Martinez, D., & Beach, D. (2004). Polycomb CBX7 has a unifying role in cellular lifespan. Nature Cell Biology, 6(1), 67-72.
120. Artero-Castro, A., Kondoh, H., Fernandez-Marcos, P. J., Serrano, M., Ramon y Cajal, S., & Lleonart, M. E. (2009). Rplp1 bypasses replicative senescence and contributes to transformation. Experimental Cell Research, 315.
121. Artero-Castro, A., Castellvi, J., Garcia, A., Hernandez, J., Ramon y Cajal, S., & Lleonart, M. E. (2011). Expression of the ribosomal proteins Rplp0, Rplp1, and Rplp2 in gynecologic tumors. Human Pathology, 42(2), 194-203.
122. Chang, T. W., Chen, C. C., Chen, K. Y., Su, J. H., Chang, J. H., & Chang, M. C. (2008). Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0 is associated with cellular proliferation in breast and liver carcinoma cells. Oncogene, 27(3), 332-338.
123. Imafuku, I., Masaki, T., Waragai, M., Takeuchi, S., Kawabata, M., Hirai, S., et al. (1999). Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1. Journal of Cell Biology, 147(1), 121-134.
124. Naora, H., Takai, I., Adachi, M., & Naora, H. (1998). Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. Journal of Cell Biology, 141(3), 741-753.
125. Yadavilli, S., Hegde, V., & Deutsch, W. A. (2007). Translocation of human ribosomal protein S3 to sites of DNA damage is dependant on ERK-mediated phosphorylation following genotoxic stress. DNA Repair (Amst), 6(10), 1453-1462.
126. Wan, F., Anderson, D. E., Barnitz, R. A., Snow, A., Bidere, N., Zheng, L., et al. (2007). Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell, 131(5), 927-939.
127. Li, C., Ge, M., Yin, Y., Luo, M., & Chen, D. (2012). Silencing expression of ribosomal protein L26 and L29 by RNA interfering inhibits proliferation of human pancreatic cancer PANC-1 cells. Molecular and Cellular Biochemistry, 370(1-2), 127-139.
128. Bee, A., Brewer, D., Beesley, C., Dodson, A., Forootan, S., Dickinson, T., et al. (2011). siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer. PLoS One, 6(7), e22672.
129. Guo, X., Shi, Y., Gou, Y., Li, J., Han, S., Zhang, Y., et al. (2011). Human ribosomal protein S13 promotes gastric cancer growth through down-regulating p27(Kip1). Journal of Cellular and Molecular Medicine, 15(2), 296-306.
130. Shuda, M., Kondoh, N., Tanaka, K., Ryo, A., Wakatsuki, T., Hada, A., et al. (2000). Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Research, 20(4), 2489-2494.
131. Kondoh, N., Shuda, M., Tanaka, K., Wakatsuki, T., Hada, A., & Yamamoto, M. (2001). Enhanced expression of S8, L12, L23a, L27 and L30 ribosomal protein mRNAs in human hepatocellular carcinoma. Anticancer Research, 21(4A), 2429-2433.
132. Wang, H., Zhao, L. N., Li, K. Z., Ling, R., Li, X. J., & Wang, L. (2006). Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer, 691.
133. Genuario, R. R., Kelley, D. E., & Perry, R. P. (1993). Comparative utilization of transcription factor GABP by the promoters of ribosomal protein genes rpL30 and rpL32. Gene Expression, 3(3), 279-288.
134. Huang, C. J., Yang, S. H., Lee, C. L., Cheng, Y. C., Tai, S. Y., & Chien, C. C. (2013). Ribosomal protein S27-like in colorectal cancer: a candidate for predicting prognoses. PLoS One, 8(6), e67043.
135. Kobayashi, T., Sasaki, Y., Oshima, Y., Yamamoto, H., Mita, H., Suzuki, H., et al. (2006). Activation of the ribosomal protein L13 gene in human gastrointestinal cancer. International Journal of Molecular Medicine, 18(1), 161-170.
136. Zheng, S. E., Yao, Y., Dong, Y., Lin, F., Zhao, H., Shen, Z., et al. (2009). Down-regulation of ribosomal protein L7A in human osteosarcoma. Journal of Cancer Research and Clinical Oncology, 135(8), 1025-1031.
137. Pogue-Geile, K., Geiser, J. R., Shu, M., Miller, C., Wool, I. G., Meisler, A. I., et al. (1991). Ribosomal protein genes are overexpressed in colorectal cancer: isolation of a cDNA clone encoding the human S3 ribosomal protein. Molecular and Cellular Biology, 11(8), 3842-3849.
138. Bertram, J., Palfner, K., Hiddemann, W., & Kneba, M. (1998). Overexpression of ribosomal proteins L4 and L5 and the putative alternative elongation factor PTI-1 in the doxorubicin resistant human colon cancer cell line LoVoDxR. European Journal of Cancer, 34(5), 731-736.
139. Hsu, Y. A., Lin, H. J., Sheu, J. J., Shieh, F. K., Chen, S. Y., Lai, C. H., et al. (2011). A novel interaction between interferon-inducible protein p56 and ribosomal protein L15 in gastric cancer cells. DNA and Cell Biology, 30(9), 671-679.
140. Dai, M. S., & Lu, H. (2004). Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. Journal of Biological Chemistry, 279(43), 44475-44482.
141. Zhang, Y., Wolf, G. W., Bhat, K., Jin, A., Allio, T., Burkhart, W. A., et al. (2003). Ribosomal protein L11 negatively regulates oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress checkpoint pathway. Molecular and Cellular Biology, 23(23), 8902-8912.
142. Jin, A., Itahana, K., O'Keefe, K., & Zhang, Y. (2004). Inhibition of HDM2 and activation of p53 by ribosomal protein L23. Molecular and Cellular Biology, 24(17), 7669-7680.
143. Rowland, B. D., & Peeper, D. S. (2006). KLF4, p21 and context-dependent opposing forces in cancer. Nature Reviews Cancer, 6(1), 11-23.
144. Castro, M. E., Leal, J. F., Lleonart, M. E., Ramon, Y. C. S., & Carnero, A. (2008). Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function. Carcinogenesis, 29(7), 1343-1350.
145. Andersen, J. B., Mazan-Mamczarz, K., Zhan, M., Gorospe, M., & Hassel, B. A. (2009). Ribosomal protein mRNAs are primary targets of regulation in RNase-l-induced senescence. RNA Biology, 6(3), 305-315.
146. Kim, M. J., Yoo, Y. A., Kim, H. J., Kang, S., Kim, Y. G., Kim, J. S., et al. (2005). Mitochondrial ribosomal protein L41 mediates serum starvation-induced cell-cycle arrest through an increase of p21(WAF1/CIP1). Biochemical and Biophysical Research Communications, 338(2), 1179-1184.
147. Khanna, N., Reddy, V. G., Tuteja, N., & Singh, N. (2000). Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer. Biochemical and Biophysical Research Communications, 277(2), 476-486.
148. Khanna, N., Sen, S., Sharma, H., & Singh, N. (2003). S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy. Biochemical and Biophysical Research Communications, 304(1), 26-35.
149. Sim, E. U., Ang, C. H., Ng, C. C., Lee, C. W., & Narayanan, K. (2010). Differential expression of a subset of ribosomal protein genes in cell lines derived from human nasopharyngeal epithelium. Journal of Human Genetics, 55(2), 118-120.
150. Robledo, S., Idol, R. A., Crimmins, D. L., Ladenson, J. H., Mason, P. J., & Bessler, M. (2008). The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA, 14(9), 1918-1929.
151. Angelini, M., Cannata, S., Mercaldo, V., Gibello, L., Santoro, C., Dianzani, I., et al. (2007). Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome. Human Molecular Genetics, 16(14), 1720-1727.
152. Dai, M. S., Zeng, S. X., Jin, Y., Sun, X. X., David, L., & Lu, H.
153. Lohrum, M. A., Ludwig, R. L., Kubbutat, M. H., Hanlon, M., & Vousden, K. H. (2003). Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell, 3(6), 577-587.
154. Chen, J., Guo, K., & Kastan, M. B. (2012). Interactions of nucleolin and ribosomal protein L26 (RPL26) in translational control of human p53 mRNA. Journal of Biological Chemistry, 287(20), 16467-16476.
155. Gao, M., Li, X., Dong, W., Jin, R., Ma, H., Yang, P., et al. (2013). Ribosomal protein S7 regulates arsenite-induced GADD45alpha expression by attenuating MDM2-mediated GADD45alpha ubiquitination and degradation. Nucleic Acids Research, 41(10), 5210-5222.
156. Sun, X. X., DeVine, T., Challagundla, K. B., & Dai, M. S. (2011). Interplay between ribosomal protein S27a and MDM2 protein in p53 activation in response to ribosomal stress. Journal of Biological Chemistry, 286(26), 22730-22741.
157. Yadavilli, S., Mayo, L. D., Higgins, M., Lain, S., Hegde, V., & Deutsch, W. A. (2009). Ribosomal protein S3: a multi-functional protein that interacts with both p53 and MDM2 through its KH domain. DNA Repair (Amst), 8(10), 1215-1224.
158. Ofir-Rosenfeld, Y., Boggs, K., Michael, D., Kastan, M. B., & Oren, M. (2008). Mdm2 regulates p53 mRNA translation through inhibitory interactions with ribosomal protein L26. Molecular Cell, 32(2), 180-189.
159. Zhang, X., Wang, W., Wang, H., Wang, M. H., Xu, W., & Zhang, R. (2013). Identification of ribosomal protein S25 (RPS25)-MDM2-p53 regulatory feedback loop. Oncogene, 32(22), 2782-2791.
160. Xiong, X., Zhao, Y., He, H., & Sun, Y. (2011). Ribosomal protein S27-like and S27 interplay with p53-MDM2 axis as a target, a substrate and a regulator. Oncogene, 30(15), 1798-1811.
161. Anderson, S. J., Lauritsen, J. P., Hartman, M. G., Foushee, A. M., Lefebvre, J. M., Shinton, S. A., et al. (2007). Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity, 26(6), 759-772.
162. Danilova, N., Sakamoto, K. M., & Lin, S. (2008). Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood, 112(13), 5228-5237.
163. Fumagalli, S., Ivanenkov, V. V., Teng, T., & Thomas, G. (2012). Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes and Development, 26(10), 1028-1040.
164. Dutt, S., Narla, A., Lin, K., Mullally, A., Abayasekara, N., Megerdichian, C., et al. (2011). Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells. Blood, 117(9), 2567-2576.
165. Morgado-Palacin, L., Llanos, S., & Serrano, M. (2012). Ribosomal stress induces L11- and p53-dependent apoptosis in mouse pluripotent stem cells. Cell Cycle, 11(3), 503-510.
166. Daftuar, L., Zhu, Y., Jacq, X., & Prives, C. (2013). Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network. PLoS One, 8(7), e68667.
167. Macias, E., Jin, A., Deisenroth, C., Bhat, K., Mao, H., Lindstrom, M. S., et al. (2010). An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 interaction. Cancer Cell, 18(3), 231-243.
168. Sun, X. X., Dai, M. S., & Lu, H. (2007). 5-fluorouracil activation of p53 involves an MDM2-ribosomal protein interaction. Journal of Biological Chemistry, 282(11), 8052-8059.
169. Bursac, S., Brdovcak, M. C., Pfannkuchen, M., Orsolic, I., Golomb, L., Zhu, Y., et al. (2012). Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proceedings of the National Academy of Sciences of the United States of America, 109(50), 20467-20472.
170. Takagi, M., Absalon, M. J., McLure, K. G., & Kastan, M. B. (2005). Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell, 123(1), 49-63.
171. Cui, D., Li, L., Lou, H., Sun, H., Ngai, S. M., Shao, G., et al. (2013). The ribosomal protein S26 regulates p53 activity in response to DNA damage. Oncogene. doi: 10.1038/onc.2013.170.1-11.
172. Landry, D. M., Hertz, M. I., & Thompson, S. R. (2009). RPS25 Is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs. Genes and Development, 23(23), 2753-2764.
173. Amsterdam, A., Sadler, K. C., Lai, K., Farrington, S., Bronson, R. T., Lees, J. A., et al. (2004). Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biology, 2(5), E139.
174. Stadanlick, J. E., Zhang, Z., Lee, S. Y., Hemann, M., Biery, M., Carleton, M. O., et al. (2011). Developmental arrest of T cells in Rpl22-deficient mice is dependent upon multiple p53 effectors. Journal of Immunology, 187(2), 664-675.
175. Panic, L., Tamarut, S., Sticker-Jantscheff, M., Barkic, M., Solter, D., Uzelac, M., et al. (2006). Ribosomal protein S6 haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol Cell Biol doi: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=17000767
176. Payne, E. M., Virgilio, M., Narla, A., Sun, H., Levine, M., Paw, B. H., et al. (2012). L-leucine improves the anemia and developmental defects associated with diamond-blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood, 120(11), 2214-2224.
177. Iadevaia, V., Caldarola, S., Biondini, L., Gismondi, A., Karlsson, S., Dianzani, I., et al. (2010). PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression. Oncogene, 29(40), 5490-5499.
178. Zhang, F., Hamanka, R. B., Bobrovnikova-Marjon, E., Gordan, J., Dai, M. S., Lu, H., et al. (2006). Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem doi: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=16893887
179. Efeyan, A., Garcia-Cao, I., Herranz, D., Velasco-Miguel, S., & Serrano, M. (2006). Tumour biology: policing of oncogene activity by p53. Nature, 443(7108), 159.
180. Yang, X. Y., Ren, C. P., Wang, L., Li, H., Jiang, C. J., Zhang, H. B., et al. (2005). Identification of differentially expressed genes in metastatic and non-metastatic nasopharyngeal carcinoma cells by suppression subtractive hybridization. Cellular Oncology, 27(4), 215-223.
181. Ishiguro, T., Nakajima, M., Naito, M., Muto, T., & Tsuruo, T. (1996). Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Research, 56(4), 875-879.
182. Kreunin, P., Yoo, C., Urquidi, V., Lubman, D. M., & Goodison, S. (2007). Differential expression of ribosomal proteins in a human metastasis model identified by coupling 2-D liquid chromatography and mass spectrometry. Cancer Genomics Proteomics, 4(5), 329-339.
183. Liu, F., Li, Y., Yu, Y., Fu, S., & Li, P. (2007). Cloning of novel tumor metastasis-related genes from the highly metastatic human lung adenocarcinoma cell line Anip973. Journal of Genetics and Genomics, 34(3), 189-195.
184. Huang, L., Zheng, M., Zhou, Q. M., Zhang, M. Y., Jia, W. H., Yun, J. P., et al. (2011). Identification of a gene-expression signature for predicting lymph node metastasis in patients with early stage cervical carcinoma. Cancer, 117(15), 3363-3373.
185. Ma, X. J., Dahiya, S., Richardson, E., Erlander, M., & Sgroi, D. C. (2009). Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Research, 11(1), R7.
186. Fernandez-Pol, J. A. (2012). Increased serum level of RPMPS-1/S27 protein in patients with various types of cancer is useful for the early detection, prevention and therapy. Cancer Genomics Proteomics, 9(4), 203-256.
187. Kim, S. H., & Kim, J. (2006). Reduction of invasion in human fibrosarcoma cells by ribosomal protein S3 in conjunction with Nm23-H1 and ERK. Biochimica et Biophysica Acta, 1763(8), 823-832.
188. Cao, X. X., Xu, J. D., Xu, J. W., Liu, X. L., Cheng, Y. Y., Wang, W. J., et al. (2010). RACK1 promotes breast carcinoma proliferation and invasion/metastasis in vitro and in vivo. Breast Cancer Research and Treatment, 123(2), 375-386.
189. Li, J., Guo, Y., Feng, X., Wang, Z., Wang, Y., Deng, P., et al. (2012). Receptor for activated C kinase 1 (RACK1): a regulator for migration and invasion in oral squamous cell carcinoma cells. Journal of Cancer Research and Clinical Oncology, 138(4), 563-571.
190. Cao, X. X., Xu, J. D., Xu, J. W., Liu, X. L., Cheng, Y. Y., Li, Q. Q., et al. (2011). RACK1 promotes breast carcinoma migration/metastasis via activation of the RhoA/Rho kinase pathway. Breast Cancer Research and Treatment, 126(3), 555-563.
191. Ould-Abeih, M. B., Petit-Topin, I., Zidane, N., Baron, B., & Bedouelle, H. (2012). Multiple folding states and disorder of ribosomal protein SA, a membrane receptor for laminin, anticarcinogens, and pathogens. Biochemistry, 51(24), 4807-4821.
192. Hundt, C., Peyrin, J. M., Haik, S., Gauczynski, S., Leucht, C., Rieger, R., et al. (2001). Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO Journal, 20(21), 5876-5886.
193. Berno, V., Porrini, D., Castiglioni, F., Campiglio, M., Casalini, P., Pupa, S. M., et al. (2005). The 67 kDa laminin receptor increases tumor aggressiveness by remodeling laminin-1. Endocrine-Related Cancer, 12(2), 393-406.
194. Umeda, D., Yano, S., Yamada, K., & Tachibana, H. (2008). Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. Journal of Biological Chemistry, 283(6), 3050-3058.
195. Skipper, M., Dhand, R., & Campbell, P. (2012). Presenting ENCODE. Nature, 489(7414), 45.
196. Lipson, D., Raz, T., Kieu, A., Jones, D. R., Giladi, E., Thayer, E., et al. (2009). Quantification of the yeast transcriptome by single-molecule sequencing. Nature Biotechnology, 27(7), 652-658.
197. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008). Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods, 5(7), 621-628.
198. Badis, G., Saveanu, C., Fromont-Racine, M., & Jacquier, A. (2004). Targeted mRNA degradation by deadenylation-independent decapping. Molecular Cell, 15(1), 5-15.
199. Meyuhas, O. (2000). Synthesis of the translational apparatus is regulated at the translational level. European Journal of Biochemistry, 267(21), 6321-6330.
200. Loayza-Puch, F., Drost, J., Rooijers, K., Lopes, R., Elkon, R., & Agami, R. (2013). p53 induces transcriptional and translational programs to suppress cell proliferation and growth. Genome Biology, 14(4), R32.
201. Nilsen, T. W., & Graveley, B. R. (2010). Expansion of the eukaryotic proteome by alternative splicing. Nature, 463(7280), 457-463.
202. Papasaikas, P., & Valcarcel, J. (2012). Evolution. Splicing in 4D. Science, 338(6114), 1547-1548.
203. Flicek, P., Ahmed, I., Amode, M. R., Barrell, D., Beal, K., Brent, S., et al. (2013). Ensembl 2013. Nucleic Acids Research, 41, D48-D55.
204. Plocik, A. M., & Guthrie, C. (2012). Diverse forms of RPS9 splicing are part of an evolving autoregulatory circuit. PLoS Genetics, 8(3), e1002620.
205. Malygin, A. A., Parakhnevitch, N. M., Ivanov, A. V., Eperon, I. C., & Karpova, G. G. (2007). Human ribosomal protein S13 regulates expression of its own gene at the splicing step by a feedback mechanism. Nucleic Acids Research, 35(19), 6414-6423.
206. Macías, S., Bragulat, M., Tardiff, D. F., & Vilardell, J. (2008). L30 binds the nascent RPL30 transcript to repress U2 snRNP recruitment. Molecular Cell, 30(6), 732-742.
207. Russo, A., Catillo, M., Esposito, D., Briata, P., Pietropaolo, C., & Russo, G. (2011). Autoregulatory circuit of human rpL3 expression requires hnRNP H1, NPM and KHSRP. Nucleic Acids Research, 39(17), 7576-7585.
208. Mitrovich, Q. M., & Anderson, P. (2000). Unproductively spliced ribosomal protein mRNAs are natural targets of mRNA surveillance in C. elegans. Genes and Development, 14(17), 2173-2184.
209. van Hoof, A., & Wagner, E. J. (2011). A brief survey of mRNA surveillance. Trends in Biochemical Sciences, 36(11), 585-592.
210. McIlwain, D. R., Pan, Q., Reilly, P. T., Elia, A. J., McCracken, S., Wakeham, A. C., et al. (2010). Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proceedings of the National Academy of Sciences of the United States of America, 107(27), 12186-12191.
211. Nguyen, L. S., Jolly, L., Shoubridge, C., Chan, W. K., Huang, L., Laumonnier, F., et al. (2012). Transcriptome profiling of UPF3B/NMD-deficient lymphoblastoid cells from patients with various forms of intellectual disability. Molecular Psychiatry, 17(11), 1103-1115.
212. McIntosh, K. B., & Warner, J. R. (2007). Yeast ribosomes: variety is the spice of life. Cell, 131(3), 450-451.
213. Komili, S., Farny, N. G., Roth, F. P., & Silver, P. A. (2007). Functional specificity among ribosomal proteins regulates gene expression. Cell, 131(3), 557-571.
214. Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013). Splicing-factor oncoprotein SRSF1 stabilizes p53 via RPL5 and induces cellular senescence. Molecular Cell, 50(1), 56-66.
215. Wang, Z., Gerstein, M., & Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nature Reviews Genetics, 10(1), 57-63.
216. Suyama, M., Harrington, E., Bork, P., & Torrents, D. (2006). Identification and analysis of genes and pseudogenes within duplicated regions in the human and mouse genomes. PLoS Computational Biology, 2(6), e76.
217. Balasubramanian, S., Zheng, D., Liu, Y. J., Fang, G., Frankish, A., Carriero, N., et al. (2009). Comparative analysis of processed ribosomal protein pseudogenes in four mammalian genomes. Genome Biology, 10(1), R2.
218. Tonner, P., Srinivasasainagendra, V., Zhang, S., & Zhi, D. (2012). Detecting transcription of ribosomal protein pseudogenes in diverse human tissues from RNA-seq data. BMC Genomics, 13412.
219. Garraway, L. A., & Lander, E. S. (2013). Lessons from the cancer genome. Cell, 153(1), 17-37.
220. Bywater, M. J., Poortinga, G., Sanij, E., Hein, N., Peck, A., Cullinane, C., et al. (2012). Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell, 22(1), 51-65.
221. Hong, D. S., Kurzrock, R., Oh, Y., Wheler, J., Naing, A., Brail, L., et al. (2011). A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer. Clinical Cancer Research, 17(20), 6582-6591.
222. Wendel, H. G., Silva, R. L., Malina, A., Mills, J. R., Zhu, H., Ueda, T., et al. (2007). Dissecting eIF4E action in tumorigenesis. Genes and Development, 21(24), 3232-3237.
223. Jiang, B. H., & Liu, L. Z. (2008). Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resistance Updates, 11(3), 63-76.
224. Meng, H., Jin, Y., Liu, H., You, L., Yang, C., Yang, X., et al. (2013). SNS-032 inhibits mTORC1/mTORC2 activity in acute myeloid leukemia cells and has synergistic activity with perifosine against Akt. Journal of Hematology & Oncology, 618.
225. Shortt, J., Martin, B. P., Newbold, A., Hannan, K. M., Devlin, J. R., Baker, A. J., et al. (2013). Combined inhibition of PI3K-related DNA damage response kinases and mTORC1 induces apoptosis in MYC-driven B-cell lymphomas. Blood, 121(15), 2964-2974.
226. Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P. H., et al. (2003). Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science, 299(5604), 259-262.
227. Campagnoli, M. F., Ramenghi, U., Armiraglio, M., Quarello, P., Garelli, E., Carando, A., et al. (2008). RPS19 mutations in patients with Diamond-Blackfan anemia. Human Mutation, 29(7), 911-920.
228. Perdahl, E. B., Naprstek, B. L., Wallace, W. C., & Lipton, J. M. (1994). Erythroid failure in diamond-blackfan anemia is characterized by apoptosis. Blood, 83(3), 645-650.
229. Gazda, H. T., Kho, A. T., Sanoudou, D., Zaucha, J. M., Kohane, I. S., Sieff, C. A., et al. (2006). Defective ribosomal protein gene expression alters transcription, translation, apoptosis and oncogenic pathways in diamond-blackfan anemia. Stem Cells doi: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd= Retrieve&db=PubMed&dopt=Citation&list-uids=16741228
230. Draptchinskaia, N., Gustavsson, P., Andersson, B., Pettersson, M., Willig, T. N., Dianzani, I., et al. (1999). The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nature Genetics, 21(2), 169-175.
231. Horos, R., Ijspeert, H., Pospisilova, D., Sendtner, R., Andrieu-Soler, C., Taskesen, E., et al. (2012). Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood, 119(1), 262-272.
232. Ebert, B. L., Pretz, J., Bosco, J., Chang, C. Y., Tamayo, P., Galili, N., et al. (2008). Identification of RPS14 as a 5q-syndrome gene by RNA interference screen. Nature, 451(7176), 335-339.
233. Wang, M., Hu, Y., & Stearns, M. E. (2009). RPS2: a novel therapeutic target in prostate cancer. Journal of Experimental & Clinical Cancer Research, 286.
234. Chen, A., Kaganovsky, E., Rahimipour, S., Ben-Aroya, N., Okon, E., & Koch, Y. (2002). Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Research, 62(4), 1036-1044.
235. Kobayashi, Y., Mizunuma, M., Osada, H., & Miyakawa, T. (2006). Identification of Saccharomyces cerevisiae ribosomal protein L3 as a target of curvularol, a G(1)-specific inhibitor of mammalian cells. Biosci Biotechnol Biochem doi: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db= PubMed&dopt=Citation&list-uids=17031058
236. Barnard, G. F., Staniunas, R. J., Mori, M., Puder, M., Jessup, M. J., Steele, G. D., Jr., et al. (1993). Gastric and hepatocellular carcinomas do not overexpress the same ribosomal protein messenger RNAs as colonic carcinoma. Cancer Research, 53(17), 4048-4052.
237. De Keersmaecker, K., Atak, Z. K., Li, N., Vicente, C., Patchett, S., Girardi, T., et al. (2013). Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nature Genetics, 45(2), 186-190.